feed,title,long_url,short_url
Benzinga,"Preprint Suggests, Vir-GSK's COVID-19 Antibody Can Evade Omicron Sub-Variant",https://benzinga.com/general/biotech/22/02/25546141/preprint-suggests-vir-gsks-covid-19-antibody-can-evade-omicron-sub-variant,https://bit.ly/3BcCCq6
